ETS2 and rheumatoid arthritis: The present study was undertaken to identify the novel mediators influenced by IL-6 signaling to accelerate the phenotypic conversion of RASFs to osteoclast-like cells and to elucidate the effects of Ets2 transcription factor in bone destruction in RA.